Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2005
12/06/2005US6972354 the plant has such traits as herbicide resistance, insect resistance, resistance for bacterial, fungal, or viral disease, male fertility, male sterility, enhanced nutritional quality, and industrial usage
12/06/2005US6972351 Methods for producing carotenoid compounds and specialty oils in plant seeds
12/06/2005US6972350 Pest-resistant plants comprising a construct encoding a vacuole targeting sequence and avidin or streptavidin
12/06/2005US6972349 Control of post-transcriptional gene silencing in plants
12/06/2005US6972328 can comprise DNA, RNA, PNA, or any combination or chimera thereof
12/06/2005US6972322 Polypeptide for use in the treatment of cancerous, angiogenesis, inflammatory shock and autoimmune diseases
12/06/2005US6972321 Monomeric protein of the TGF-β family
12/06/2005US6972197 Transforming cells with centromeres to form transgenic plants; genetic engineering
12/06/2005US6972193 dimerization or oligomerization of intracellular proteins to activate genetic transcription; signal transduction and activators of transcription
12/06/2005US6972190 Polynucleotide with the activity of carbon starvation protein A (cstA); fermentative preparation of L-amino acids, such as L-lysine
12/06/2005US6972186 Nucleic acid encoding pro 1410 polypeptides
12/06/2005US6972185 For use as pharmaceuticals, diagnostics, biosensors and bioreactors
12/06/2005US6972183 generating expression libraries comprising vectors having nucleic acid sequences from microorganisms, then mixing with substrates preferential for enzymes, incubating and analyzing signals produced; microfluidics; screening for biological targets
12/06/2005US6972179 RRP sequences and knockout mice and uses thereof
12/06/2005US6972178 transfecting cells with genes, expressing regulatory proteins and codes for nuclear receptors, then culturing with chemicals and analyzing; bioassay; genetic engineering
12/06/2005US6972176 KVLQT1—a long QT syndrome gene
12/06/2005US6972171 mixing polynucleotides with folic acid, hormones, peptides, glycoproteins, lipids or phosphatides to form nucleotides used as drugs; genetic engineering; gene expression
12/06/2005US6972127 administering an effective dose of a polypeptide comprising an immunogenic fragment of A beta (SEQ ID NO:1) and an adjuvant in a regime effective to induce an immune response comprising antibodies to the A beta fragment; Alzheimer's disease
12/06/2005CA2325854C A method for the characterisation of nucleic acid molecules involving generation of extendible upstream dna fragments resulting from the cleavage of nucleic acid at an abasic site
12/06/2005CA2201871C An enzyme and enzyme preparation with endoglucanase activity
12/06/2005CA2164324C Generation concentration and efficient transfer of vsv-g pseudotyped retroviral vectors
12/06/2005CA2133417C Oil-body protein cis-elements as regulatory signals
12/06/2005CA2073282C Human herpesvirus type 6 protein p100, the corresponding dna sequences, their preparation and use
12/06/2005CA2013524C Cloning genes from streptomyces avermitilis for avermectin biosynthesis and the methods for their use
12/01/2005WO2005114215A2 Method of improving t cell receptors
12/01/2005WO2005113827A2 Construction of live attenuated shigella vaccine strains that express cfa/i antigens (cfab and cfae) and the b subunit of heat-labile enterotoxin (ltb) from enterotoxigenic e. coli
12/01/2005WO2005113821A1 Approaches to identify less harmful tobacco and tobacco products
12/01/2005WO2005113817A2 Aptamer-nanoparticle conjugates and method of use for target analyte detection
12/01/2005WO2005113813A2 Nucleic acid ligands specific to immunoglobulin e and their use as atopic disease therapeutics
12/01/2005WO2005113811A2 Combinatorial selection of phosphorothioate aptamers for tgf-beta
12/01/2005WO2005113808A1 Method for plasmid preparation by conversion of open circular plasmid ot supercoiled plasmid
12/01/2005WO2005113806A1 Method of diagnosing uveitis
12/01/2005WO2005113792A1 Probe for detection/determination of inositol-1,4,5-triphosphoric acid and method of detecting/determining inositol-1,4,5-triphosphoric acid with the same
12/01/2005WO2005113782A1 Tc-83-derived alphavirus vectors, particles and methods
12/01/2005WO2005113781A2 Vectors for use in gene and cancer therapy
12/01/2005WO2005113780A1 Adipose-derived stem cells and lattices
12/01/2005WO2005113779A2 Plant myo-inositol kinase polynucleotides and methods of use
12/01/2005WO2005113778A2 Maize multidrug resistance-associated protein polynucleotides and methods of use
12/01/2005WO2005113777A1 Means and methods for producing stress-resistant plants
12/01/2005WO2005113776A2 Expression cassette
12/01/2005WO2005113775A1 Pproduction of a protein localized to the endoplasmic reticulum protein bodies in a transgenic plant and seed
12/01/2005WO2005113774A2 Methods for production of xylitol in microorganisms
12/01/2005WO2005113773A1 Polynucleotides for the detection of escherichia coli 0157:h7 and escherichia coli 0157:nm verotoxin producers
12/01/2005WO2005113772A1 Fluorescent protein
12/01/2005WO2005113771A1 An embryo preferred promoter and method of using same
12/01/2005WO2005113770A1 Anti-rhoa and -rhoc sirnas and therapeutic compositions comprising them.
12/01/2005WO2005113769A1 Method for stabilizing biological samples for nucleic acid analysis
12/01/2005WO2005113768A1 Process for producing polypeptide
12/01/2005WO2005113767A1 Plasmid responsive to dioxin, etc., transgenic cell for assay of dioxin, etc. and utilizing the same, dioxin, etc. detecting method and biosensor
12/01/2005WO2005113766A1 Modified ethylenediamine-n,n’-disuccinic acid:ethylenediamine lyase
12/01/2005WO2005113764A2 Modulation of wrn-mediated telomere-initiated cell signaling
12/01/2005WO2005113760A2 Thermostable y-family polymerases and chimeras
12/01/2005WO2005113745A1 Succinic acid-producing bacterium and process for producing succinic acid
12/01/2005WO2005113744A1 Succinic acid-producing bacterium and process for producing succinic acid
12/01/2005WO2005113643A1 Polyamide resin and hinged molded articles
12/01/2005WO2005113599A1 C1q family member proteins with altered immunogenicity
12/01/2005WO2005113591A1 Chimeric soluble hyper il-11 and use thereof
12/01/2005WO2005113589A2 Modified antigen-presenting cells
12/01/2005WO2005113586A2 Disease-associated proteins
12/01/2005WO2005113584A1 Methods and compositions comprising protein l immunoglobulin binding domains for cell-specific targeting
12/01/2005WO2005113583A1 An expression system comprising operably linked rgg gene and gtfg promoter
12/01/2005WO2005113571A2 Methods for the delivery of oligomeric compounds
12/01/2005WO2005113017A2 Gfap-based gene therapy for treatment of retinal diseases
12/01/2005WO2005113016A2 Modulation of glucose-6-phosphatase translocase expression
12/01/2005WO2005113015A1 Enhanced gene delivery using viral vectors
12/01/2005WO2005113014A1 siRNA TO VP-1 OF JC VIRUS AND MEDICINAL COMPOSITION CONTAINING THE SAME
12/01/2005WO2005112979A2 Methods of preventing and treating alimentary mucositis
12/01/2005WO2005112886A2 Methods and articles for the delivery of therapeutic agents
12/01/2005WO2005112885A2 Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1
12/01/2005WO2005112636A2 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF PRIMATE POLYOMAVIRUS GENES
12/01/2005WO2005112622A2 Regulation of transcription with a cis-acting ribozyme
12/01/2005WO2005112621A2 A murine model of hiv-1 infection
12/01/2005WO2005112620A2 A cre-lox based method for conditional rna interference
12/01/2005WO2005112619A2 Novel gene disruptions, compositions and methods relating thereto
12/01/2005WO2005112609A2 Promotion of somatic embryogenesis in plants by pga37 gene expression
12/01/2005WO2005112608A2 Modified plant transcription factors
12/01/2005WO2005112597A2 Transgenic plants expressing intein modified proteins and associated processes for bio-pharmaceutical production
12/01/2005WO2005112541A2 Adenovirus/alphavirus hybrid vector for the effective administration and expression of therapeutic genes in tumour cells
12/01/2005WO2005099335A3 Methods for predicting the risk of diabetic nephropathy using genetic markers and arrays containing the same
12/01/2005WO2005098004A3 Inducible boost of integrated satellite rna viruses
12/01/2005WO2005095653A3 Method for collecting purified cells
12/01/2005WO2005095620A3 Methods and compositions for regulating plant stress tolerance
12/01/2005WO2005092379A3 Materials and methods for treatment of cancer
12/01/2005WO2005092059A3 Compositions for use in identification of viral hemorrhagic fever viruses
12/01/2005WO2005082930A3 An immunoreactive 38-kda ferric binding protein of ehrlichia canis and uses thereof
12/01/2005WO2005078090A3 Antisense oligonucleotides for treating unwanted pigmentation of the skin and hair
12/01/2005WO2005070967A3 Anti-cancer antibodies with reduced complement fixation
12/01/2005WO2005065015A3 Neutralizing antibodies and methods of use thereof
12/01/2005WO2005058938A3 Helical synthetic peptides that stimulate cellular cholesterol efflux
12/01/2005WO2005051977A3 Conditional allele system
12/01/2005WO2005040336B1 Dna cloning vector plasmids and methods for their use
12/01/2005WO2005032595A3 Methods and compositions for the inhibition of stat5 in prostate cancer cells
12/01/2005WO2005014858A3 Qtl 'mapping as-you-go'
12/01/2005WO2005014806A3 Conserved hbv and hcv sequences useful for gene silencing
12/01/2005WO2005010794A3 Method for determining metabolic flux affecting substance production
12/01/2005WO2005009460A3 Pharmaceutical composition comprising activin a, alk-4 or derivatives thereof for the treatment of ophthalmic disorders or cancer
12/01/2005WO2005007859A3 Rna interference mediated inhibition of acetyl-coa carboxylase gene expression using short interfering nucleic acid (sina)
12/01/2005WO2005001032A3 Fine mapping of chromosome 17 quantitative trait loci and use of same for marker assisted selection
12/01/2005WO2004072259A8 Altered fad2 and fad3 genes in brassica and the molecular marker-assisted detection thereof
12/01/2005WO2004071186A8 Animal model for inflammatory bowel disease
1 ... 1902 1903 1904 1905 1906 1907 1908 1909 1910 1911 1912 1913 1914 1915 1916 1917 1918 1919 1920 1921 1922 ... 4023